Skip to main content
. Author manuscript; available in PMC: 2008 Dec 11.
Published in final edited form as: Int J Approx Reason. 2008 Jan;47(1):17–36. doi: 10.1016/j.ijar.2007.03.006

Table 1.

Data sets used for classification analysis.

Cancer site Classes Samples Features Reference
Brain 2 60 (21 censored, 39 failures) 7,129 Pomeroy et al[12]
Prostate 2 102 (52 tumor, 50 normal) 12,600 Singh et al[13]
Breast 2 15 (8 BRCA1, 7 BRCA2) 3,170 Hedenfalk et al. [14]
Breast 2 78 (34 relapse, 44 non-relapse) 24,481 van ’t Veer et al[15]
Colon 2 62 (40 negative, 22 positive) 2,000 Alon et al[16]
Lung 2 32 (16 MPM, 16 ADCA) 12,533 Gordon et al[20]
Leukemia 2 38 (27 ALL, 11 AML) 7,129 Golub et al [21]
Leukemia 3 57 (20 ALL, 17 MLL, 20 AML) 12,582 Armstrong et al[22]
SRBCT 4 63 (23 EWS, 8 BL, 12 NB, 20 RMS) 2,308 Khan et al[23]